Mediator Appointed to Oversee Negotiations to Settle Pradaxa Cases
A mediator has been appointed to meet monthly with parties in the Pradaxa MDL to discuss settling cases.
A mediator has been appointed to meet monthly with parties in the Pradaxa MDL to discuss settling cases.
A recall has been issued for Ad-Tech Medical Instrument Corporation’s Macro Micro Subdural Electrodes, due to a potential risk that the device may cause damage to brain tissue and the…
In response to a request filed by plaintiffs to centralize all federal Pradaxa lawsuits, which involve claims brought by former users of the anticoagulant who suffered uncontrolled bleeding, Boehringer Ingelheim…
A new study has identified possible ways to reverse the effects of a proposed blood thinner that belongs to the same class of anticoagulants as Pradaxa, which has been associated…
A motion has been filed to consolidate the Pradaxa litigation in the federal court system as part of an MDL (multidistrict litigation), centralizing all product liability lawsuits over the anticoagulant…
The blood thinner Pradaxa was linked to hundreds of deaths in the the United States last year, according to a new report on adverse events submitted to the FDA, and…
The lack of a fast method to reverse the bleeding side effects of Pradaxa is proving lethal to many patients, according to a newly published case study.
More than 500 reports of Pradaxa bleeding problems were reported to the FDA in the first quarter of 2011, just months after the drug first hit the market.
A recent study involving the review of clinical data on the controversial new anticoagulent Pradaxa found an increased risk of heart attacks when compared to warfarin, but an overall decrease…
Experts and regulators are growing more and more concerned over Pradaxa bleeding problems, causing individuals who experienced serious and life-threatening injuries to question whether the drug maker failed to adequately…